Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Glycopyrrolate

Glycopyrrolate Range

Comprehensive Glycopyrrolate portfolio for Franchise & Manufacturing.

Category
glycopyrrolate
Total Formulations
6
Available Forms
Capsule, Inhaler, Rota Cap, Spray
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Glycopyrrolate portfolio by Dosage Form

Capsule
Inhaler
Rota Cap
Spray

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Glycopyrrolate batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Glycopyrrolate Product Range & PCD Franchise

Glycopyrrolate PCD Pharma Franchise Company

Cafoli Lifecare offers 6 Glycopyrrolate formulations across inhalers, rota caps, capsules and sprays for PCD pharma franchise and third-party manufacturing. Every batch is produced in WHO-GMP certified facilities, giving distributors a focused respiratory and antimuscarinic range.

What is Glycopyrrolate?

Glycopyrrolate (glycopyrronium) is a long-acting antimuscarinic (anticholinergic) agent. As an inhaled long-acting muscarinic antagonist (LAMA) it produces sustained bronchodilation in chronic obstructive pulmonary disease, and in injectable or oral form it is used to reduce airway and salivary secretions. See MedlinePlus for detailed drug information.

Therapeutic Applications

Inhaled glycopyrrolate is used for maintenance bronchodilation in COPD; other forms are used to control excessive secretions peri-operatively and in chronic sialorrhoea. It is prescribed chiefly by pulmonologists, chest physicians, anaesthetists and general physicians.

Why Glycopyrrolate is a High-Potential Molecule for Distributors

COPD prevalence in India is high and rising, and LAMA therapy is a daily maintenance treatment continued over years, which makes glycopyrrolate a dependable repeat-prescription molecule. Inhaler and rota cap formats align with the fast-growing respiratory-device segment, letting franchise partners build recurring revenue around chest-physician relationships.

Why Choose Cafoli Lifecare

Cafoli Lifecare supports partners with monopoly PCD rights, WHO-GMP manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners across India.

References

  1. MedlinePlus – Glycopyrrolate Oral Inhalation
  2. PubChem – Glycopyrrolate
  3. PubMed – Glycopyrronium in COPD

Aceclofenac in Modern Clinical Practice

Our formulations of Glycopyrrolate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Glycopyrrolate in PCD Franchise

Start Your Glycopyrrolate Franchise with Cafoli Lifecare

Secure monopoly rights for the Glycopyrrolate respiratory range in your district today. Call 9518447302 or email info@cafoli.in for net rates and franchise terms.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 6 Glycopyrrolate formulations across inhalers, rota caps, capsules and sprays, made in WHO-GMP certified facilities. Contact us for compositions and net rates.

Monopoly rights are granted district-wise or area-wise, keeping you the sole Cafoli Lifecare partner for the Glycopyrrolate range in your territory.

Inhaled glycopyrrolate is prescribed mainly by pulmonologists and chest physicians for COPD, while injectable and oral forms are used by anaesthetists and physicians to control secretions.

As a long-acting muscarinic antagonist (LAMA), glycopyrrolate is a maintenance COPD therapy taken daily for years, generating consistent refill demand from a growing respiratory patient base.

A valid Drug License and GST registration are required. Our team supports you through onboarding and the franchise agreement.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited